The women’s health and beauty supplements market size was estimated at US$ 53.44 billion in 2022 it is predicted to grow at a CAGR of 5.12% from 2023 to 2032 to reach around US$ 88.05 billion by the end of 2032.
The women’s health and beauty supplements market report offers an exclusive study of the present state expected at the market dynamics, opportunities, market scheme, growth analysis and regional outlook. The report presents energetic visions to conclude and study the market size, market aspiration, and competitive environment. The research also focuses on the important achievements of the market, research & development, and regional (country by country) growth of the leading vendors operating in the market
The study offers intricate dynamics about different aspects of the global women’s health and beauty supplements market, which aids companies operating in the market in making strategies development decisions. The study also elaborates on remarkable changes that are highly anticipated to configure growth of the global women’s health and beauty supplements market during the forecast period. It also includes a key indicator analysis that highlights growth prospects of this market and approximate statistics related to growth of the market in terms of value (US$ Bn) and volume (tons).
Sample Link @ https://www.visionresearchreports.com/report/sample/40075
Report Scope of the Women’s Health And Beauty Supplements Market
| Report Coverage | Details |
| Market Size in 2022 | USD 53.44 billion |
| Revenue Forecast by 2032 | USD 88.05 billion |
| Growth rate from 2023 to 2032 | CAGR of 5.12% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Herbalife International of America, Inc.; GNC Holdings, Inc.; Nature’s Bounty; Bayer AG; Suntory Holdings Limited; Taisho Pharmaceutical Co., Ltd; Pharmavite LLC; Pfizer, Inc.; Blackmores; FANCL Corporation; Asahi Group Holdings, Ltd.; USANA Health Sciences, Inc.; Nu Skin Enterprise, Inc.; BY-HEALTH Co., Ltd.; Revital Ltd.; The Himalaya Drug Company; Vita Life Sciences; Standard Foods Corporation; garden of life (Nestlé) |
This study covers an elaborate segmentation of the global women’s health and beauty supplements market, along with important information and a competition outlook. The report mentions company profiles of players that are currently influence the global women’s health and beauty supplements market, wherein various developments, expansions, and winning strategies practiced and execute by leading players have been presented in detail.
Women’s Health And Beauty Supplements Market Segmentations:
| By Product | By Application | By Age-Group | By Consumer Group | By Sales Channel |
| Vitamins
Mineral Enzymes Botanicals Proteins Omega-3 Probiotics Others |
Beauty
Women’s Health |
Age 15-30
Age 31-50 Age 51-70 Above 70 years |
Prenatal
Postnatal PMS Perimenopause Postmenopause Others |
Online
Direct Sales Pharmacies/Drug Stores Other Offline Channels |
Research Methodology
The research methodology acquire by analysts for assemble the global women’s health and beauty supplements market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts study numerous annual report declaration, white papers, market association declaration, and company websites to obtain the necessary understanding of the global women’s health and beauty supplements market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Women’s Health And Beauty Supplements Market
5.1. COVID-19 Landscape: Women’s Health And Beauty Supplements Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Women’s Health And Beauty Supplements Market, By Product
8.1. Women’s Health And Beauty Supplements Market, by Product, 2023-2032
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Mineral
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Enzymes
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Botanicals
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Proteins
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Omega-3
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Probiotics
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Women’s Health And Beauty Supplements Market, By Beauty
9.1. Women’s Health And Beauty Supplements Market, by Application, 2023-2032
9.1.1. Beauty
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Women’s Health
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Women’s Health And Beauty Supplements Market, By Age-Group
10.1. Women’s Health And Beauty Supplements Market, by Age-Group, 2023-2032
10.1.1. Age 15-30
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Age 31-50
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Age 51-70
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Above 70 years
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Women’s Health And Beauty Supplements Market, By Consumer Group
11.1. Women’s Health And Beauty Supplements Market, by Consumer Group, 2023-2032
11.1.1. Prenatal
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Postnatal
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. PMS
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Perimenopause
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Postmenopause
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. Others
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Women’s Health And Beauty Supplements Market, By Sales Channel
12.1. Women’s Health And Beauty Supplements Market, by Sales Channel, 2023-2032
12.1.1. Online
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Direct Sales
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Pharmacies/Drug Stores
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Other Offline Channels
12.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Women’s Health And Beauty Supplements Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.1.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.1.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.1.7. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.1.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.1.8.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.1.8.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.1.8.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.2.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.2.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.2.7. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.2.8. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.2.10. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.2.11. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.2.13. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Application (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.2.15. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.3.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.3.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.3.7. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.3.9. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.3.10.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.3.11.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.4.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.4.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.4.7. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.4.9. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.4.10.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.4.11.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.5.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.5.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.5.7. Market Revenue and Forecast, by Sales Channel (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Age-Group (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Consumer Group (2020-2032)
13.5.8.5. Market Revenue and Forecast, by Sales Channel (2020-2032)
Chapter 14. Company Profiles
14.1. Herbalife International of America, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. GNC Holdings, Inc
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Nature’s Bounty
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Bayer AG
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Suntory Holdings Limited
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Taisho Pharmaceutical Co., Ltd
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Pharmavite LLC
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Pfizer, Inc
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Blackmores
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. FANCL Corporation
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Vision Research Reports
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168